A randomised controlled trial to assess the impact of a lifestyle intervention (ActWELL) in women invited to NHS breast screening

niversity of Dundee0 个研究点目标入组 560 人开始时间: 2017年7月21日最近更新: 2024年8月19日

适应症

试验速览

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30413516 protocol 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32503606/ feasibility and optimisation results (added 08/06/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33676538/ (added 18/06/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34090495/ Letter (added 05/08/2024) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33968362/ SWAT 76 evaluation (added 05/08/2024)

•1. Invited to attend, or attended, routine breast screening clinics (not recall clinics)
•2. Measured BMI >25 kg/m2
•3. Women aged 50-70 years

•1. Currently undergoing treatment for any malignant condition
•2. Reported contra-indication to physical activity (e.g. recent surgery)
•3. Reported contra-indication to weight management (e.g. currently following a recovery programme for weight gain)
•4. Diagnosis of Type 1 diabetes
•5. No telephone contact
•6. Current use of insulin
•7. Unable to consent
•8. On a special or prescribed diet e.g. gluten free

发起方

niversity of Dundee